Last updated on October 2018

MRI Screening for Patients With Myelodysplastic Syndrome (MDS) Who Have Received Multiple Red Blood Cell Transfusions

Brief description of study

A known risk of red blood cell transfusions is that it puts excess iron into the patient's body. Researchers are continually seeking the most effective method of measuring iron concentration. The purpose of this study is to determine how much iron has been deposited in a patient's heart and liver as a result of having received red blood cell transfusions using magnetic resonance imaging (MRI).

Clinical Study Identifier: NCT00749372

Contact Investigators or Research Sites near you

Start Over

Eric Feldman, M.D.

Weill Medical College of Cornell University
New York, NY United States

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.